Dishman Carbogen Amcis Limited - Asset Resilience Ratio

Latest as of September 2025: 5.68%

Dishman Carbogen Amcis Limited (DCAL) has an Asset Resilience Ratio of 5.68% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Dishman Carbogen Amcis Limited strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs6.31 Billion

≈ $68.29 Million USD Cash + Short-term Investments

Total Assets

Rs111.09 Billion

≈ $1.20 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Dishman Carbogen Amcis Limited's Asset Resilience Ratio has changed over time. See DCAL net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Dishman Carbogen Amcis Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Dishman Carbogen Amcis Limited (DCAL) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs6.16 Billion	5.54%
Short-term Investments	Rs157.30 Million	0.14%
Total Liquid Assets	Rs6.31 Billion	5.68%

Asset Resilience Insights

Limited Liquidity: Dishman Carbogen Amcis Limited maintains only 5.68% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Dishman Carbogen Amcis Limited Industry Peers by Asset Resilience Ratio

Compare Dishman Carbogen Amcis Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Dishman Carbogen Amcis Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Dishman Carbogen Amcis Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.35%	Rs354.30 Million ≈ $3.83 Million	Rs99.99 Billion ≈ $1.08 Billion	-1.42pp
2024-03-31	1.77%	Rs1.70 Billion ≈ $18.38 Million	Rs95.81 Billion ≈ $1.04 Billion	-0.62pp
2023-03-31	2.40%	Rs2.26 Billion ≈ $24.49 Million	Rs94.53 Billion ≈ $1.02 Billion	-1.59pp
2022-03-31	3.98%	Rs3.44 Billion ≈ $37.22 Million	Rs86.37 Billion ≈ $934.11 Million	+1.74pp
2021-03-31	2.24%	Rs1.88 Billion ≈ $20.29 Million	Rs83.66 Billion ≈ $904.76 Million	+0.60pp
2020-03-31	1.64%	Rs1.35 Billion ≈ $14.57 Million	Rs82.00 Billion ≈ $886.78 Million	+1.00pp
2019-03-31	0.64%	Rs471.10 Million ≈ $5.09 Million	Rs73.28 Billion ≈ $792.55 Million	-1.08pp
2018-03-31	1.73%	Rs1.24 Billion ≈ $13.40 Million	Rs71.76 Billion ≈ $776.11 Million	+1.42pp
2017-03-31	0.30%	Rs199.20 Million ≈ $2.15 Million	Rs65.93 Billion ≈ $713.05 Million	+0.18pp
2016-03-31	0.12%	Rs36.30 Million ≈ $392.57K	Rs29.81 Billion ≈ $322.33 Million	-0.35pp
2015-03-31	0.47%	Rs132.00 Million ≈ $1.43 Million	Rs28.13 Billion ≈ $304.22 Million	+0.47pp
2013-03-31	0.00%	Rs117.00K ≈ $1.27K	Rs23.15 Billion ≈ $250.35 Million	-0.20pp
2012-03-31	0.21%	Rs46.13 Million ≈ $498.86K	Rs22.49 Billion ≈ $243.22 Million	-0.07pp
2011-03-31	0.27%	Rs56.35 Million ≈ $609.41K	Rs20.82 Billion ≈ $225.19 Million	+0.27pp
2008-03-31	0.00%	Rs-1.00K ≈ $-10.81	Rs14.70 Billion ≈ $158.94 Million	-0.36pp
2005-03-31	0.36%	Rs11.65 Million ≈ $126.00K	Rs3.22 Billion ≈ $34.84 Million	--

pp = percentage points

About Dishman Carbogen Amcis Limited

NSE:DCAL India Biotechnology

Market Cap

$284.60 Million

Rs26.32 Billion INR

Market Cap Rank

#15191 Global

#760 in India

Share Price

Rs167.85

Change (1 day)

-4.71%

52-Week Range

Rs129.97 - Rs314.40

All Time High

Rs389.62